Published Date: 31-Jan-2020
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Oculoplastic Surgery Market, published by KBV Research, The Global Oculoplastic Surgery Market size is expected to reach $10.1 billion by 2025, rising at a market growth of 5.75% CAGR during the forecast period. Rapidly increasing disposable income, higher acceptance of various oculoplastic procedures, and willingness to spend on esthetic surgery are other factors that drive market growth.
The eyelid surgery segment recorded a dominant market share in 2018. Eyelid surgery, also known as an eye lift or blepharoplasty, extracts excess skin from the upper eyelids and eliminates weight from the lower eyelids. The Orbital Surgery market is expected to witness a CAGR of 6.3% during (2019 - 2025).
Ambulatory surgical centers accounted for the largest market share in 2018 and the segment is projected to dominate the market all through the forecast period. The large market share of this segment has been associated with the increasing number of outpatient surgeries that do not need hospital stays. The hospital segment is also expected to see significant growth during the forecast period.
North America dominated the market in 2018 because of the increased rate of procedures and the high cost of treatment. North America has a huge addressable population, with millennial aesthetic usage levels tripled in the US alone over the last four years. Asia Pacific is expected to post the fastest CAGR over the forecast period. The cost of plastic surgery performed in developed countries as compared to developing countries varies considerably, which is the primary driver of regional growth.
Structural Insights: https://www.kbvresearch.com/oculoplastic-surgery-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Karl Storz SE & Co. KG, Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH), Stanford Health Care, Tekno-Medical Optik-Chirurgie GmbH, Bolton Surgical Ltd., Blink Medical Ltd. (Katena Products, Inc.), and Sklar Corporation.
By End Use
Unique Offerings from KBV Research